Bacillus subtilis, composite preparation, and method for preparing the composite preparation
A technology of Bacillus subtilis and compound preparations, applied in biochemical equipment and methods, bacteria, pharmaceutical formulations, etc., can solve the problems of no antagonism, no antibiotic resistance, etc., to reduce drug residues, improve sensitivity, improve safety effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example
[0081] Composition of compound preparations. Based on Bacillus subtilis LY-35 and E. Coli, Salmonella D enteriditis, Staphylococcus aureus, Streptococcus Pyogenes, Proteus mirabili, Proteus Vulgaris, Pseudomonas aeruginosa, and Klebsillapneumoniae phages with typical morphology, culture, and biochemical characteristics, four composites were prepared. Preparations, for the convenience of use and transportation, the compound preparations are concentrated preparations.
[0082] The first preparation contains
[0083] 1. The number of viable bacteria of Bacillus subtilis LY-35 in one milliliter of compound preparation is 1×10 9 .
[0084] 2. The phage titer of one milliliter compound preparation E.Coli, Salmonella D, enteriditi, Staphylococcus aureus, Streptococcus Pyogenes, Proteus mirabilis, Proteus Vulgaris, Pseudomonasaeruginosa, Klebsilla pneumoniae is 10 6 (ten-fold serial dilution method).
[0085] 3. Enzyme inhibition stabilizer: 0.5% EDTA (ethylenediaminetetraacetic a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com